See more : GSI Creos Corporation (8101.T) Income Statement Analysis – Financial Results
Complete financial analysis of Enovis Corporation (0I1B.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Enovis Corporation, a leading company in the Industrial – Capital Goods industry within the Industrials sector.
- Restaurant Brands International Inc. (QSR.TO) Income Statement Analysis – Financial Results
- Bojun Education Company Limited (1758.HK) Income Statement Analysis – Financial Results
- China Ever Grand Financial Leasing Group Co., Ltd. (0379.HK) Income Statement Analysis – Financial Results
- PT Wira Global Solusi Tbk (WGSH.JK) Income Statement Analysis – Financial Results
- PTC India Limited (PTC.BO) Income Statement Analysis – Financial Results
Enovis Corporation (0I1B.L)
About Enovis Corporation
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.71B | 1.56B | 3.85B | 3.07B | 3.33B | 3.67B | 3.30B | 3.65B | 3.97B | 4.62B | 4.21B | 3.91B | 693.39M | 541.99M | 525.02M | 604.85M | 506.31M | 393.60M | 345.48M | 309.65M |
| Cost of Revenue | 716.42M | 693.72M | 2.24B | 1.78B | 1.93B | 2.53B | 2.27B | 2.50B | 2.72B | 3.15B | 2.90B | 2.76B | 453.29M | 350.58M | 339.24M | 387.67M | 330.71M | 256.81M | 222.35M | 197.91M |
| Gross Profit | 990.78M | 869.38M | 1.61B | 1.29B | 1.40B | 1.13B | 1.03B | 1.15B | 1.25B | 1.48B | 1.31B | 1.15B | 240.10M | 191.41M | 185.79M | 217.19M | 175.59M | 136.80M | 123.13M | 111.75M |
| Gross Profit Ratio | 58.04% | 55.62% | 41.87% | 41.95% | 42.11% | 30.89% | 31.19% | 31.41% | 31.55% | 31.98% | 31.05% | 29.44% | 34.63% | 35.32% | 35.39% | 35.91% | 34.68% | 34.76% | 35.64% | 36.09% |
| Research & Development | 75.33M | 60.83M | 49.09M | 68.60M | 61.80M | 34.20M | 42.90M | 39.30M | 41.50M | 43.00M | 27.40M | 19.40M | 5.71M | 6.21M | 5.93M | 5.86M | 4.16M | 3.34M | 2.86M | 3.18M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 843.99M | 879.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.00M | 15.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 830.31M | 772.91M | 1.33B | 1.09B | 1.13B | 818.21M | 732.34M | 825.24M | 905.95M | 1.01B | 860.99M | 895.45M | 144.82M | 119.43M | 113.67M | 125.23M | 98.50M | 113.92M | 92.71M | 77.43M |
| Other Expenses | 150.85M | 126.30M | 11.21M | 0.00 | -33.62M | 39.00K | -46.93M | -8.23M | -21.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -50.35M | 0.00 | 0.00 | 29.41M |
| Operating Expenses | 1.06B | 960.04M | 1.33B | 1.09B | 1.13B | 818.21M | 732.34M | 825.24M | 905.95M | 1.01B | 860.99M | 895.45M | 150.52M | 125.63M | 117.41M | 200.50M | 52.32M | 117.26M | 95.56M | 110.02M |
| Cost & Expenses | 1.77B | 1.65B | 3.57B | 2.87B | 3.06B | 3.35B | 3.00B | 3.33B | 3.62B | 4.16B | 3.76B | 3.66B | 603.82M | 476.21M | 456.65M | 588.17M | 383.03M | 374.06M | 317.91M | 307.93M |
| Interest Income | 0.00 | 200.00K | 200.00K | 3.20M | 3.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 19.75M | 24.05M | 72.59M | 104.26M | 119.50M | 44.05M | 41.14M | 30.02M | 47.74M | 51.31M | 103.60M | 91.57M | 5.92M | 6.68M | 7.21M | 11.82M | 0.00 | 0.00 | 0.00 | 6.92M |
| Depreciation & Amortization | 217.10M | 202.90M | 187.00M | 246.23M | 236.03M | 141.88M | 123.42M | 109.87M | 154.54M | 174.72M | 119.26M | 200.40M | 22.60M | 16.13M | 15.07M | 14.79M | 16.88M | 13.14M | 12.91M | 0.00 |
| EBITDA | 169.92M | 225.78M | 95.03M | 180.05M | 409.22M | 330.29M | 160.41M | 349.27M | 430.59M | 409.55M | 525.65M | 140.01M | 25.91M | 34.37M | 54.70M | 16.69M | 140.16M | 32.68M | 38.99M | 1.73M |
| EBITDA Ratio | 9.95% | 8.39% | 14.49% | 14.55% | 14.16% | 12.45% | 11.66% | 12.49% | 12.61% | 13.89% | 13.42% | 6.56% | 12.92% | 15.11% | 15.89% | 5.20% | 17.74% | 8.30% | 11.72% | 0.56% |
| Operating Income | -65.71M | -88.57M | 256.64M | 162.29M | 203.61M | 236.94M | 29.15M | 238.02M | 284.65M | 409.55M | 406.39M | 140.01M | 25.91M | 34.37M | 38.46M | 16.69M | 123.28M | 19.54M | 27.56M | 1.73M |
| Operating Income Ratio | -3.85% | -5.67% | 6.66% | 5.29% | 6.12% | 6.46% | 0.88% | 6.53% | 7.18% | 8.86% | 9.66% | 3.58% | 3.74% | 6.34% | 7.33% | 2.76% | 24.35% | 4.97% | 7.98% | 0.56% |
| Total Other Income/Expenses | -1.42M | 36.12M | -58.98M | -104.26M | -153.12M | -59.17M | -147.58M | -30.32M | -28.72M | -51.31M | -103.60M | -91.57M | -5.92M | -6.68M | -6.04M | -11.82M | -19.25M | -14.19M | -9.03M | -6.92M |
| Income Before Tax | -67.13M | -2.07M | 165.39M | 58.03M | 50.49M | 182.80M | -11.99M | 208.00M | 236.90M | 358.25M | 302.80M | 48.44M | 19.99M | 27.69M | 31.25M | 4.87M | 104.03M | 5.36M | 18.54M | -5.19M |
| Income Before Tax Ratio | -3.93% | -0.13% | 4.29% | 1.89% | 1.52% | 4.99% | -0.36% | 5.70% | 5.97% | 7.75% | 7.20% | 1.24% | 2.88% | 5.11% | 5.95% | 0.80% | 20.55% | 1.36% | 5.37% | -1.68% |
| Income Tax Expense | -13.29M | 36.12M | 66.70M | -6.05M | 31.63M | -21.00K | 42.55M | 62.81M | 49.72M | -62.03M | 93.65M | 90.70M | 15.43M | 11.47M | 9.53M | 5.44M | 39.15M | 3.87M | 6.91M | -6.01M |
| Net Income | -33.26M | -38.19M | 98.69M | 64.08M | 18.86M | 140.20M | 151.09M | 128.11M | 167.74M | 392.10M | 178.63M | -64.40M | 4.56M | 16.22M | 21.72M | -571.00K | 64.88M | 94.00K | 12.25M | 57.31M |
| Net Income Ratio | -1.95% | -2.44% | 2.56% | 2.09% | 0.57% | 3.82% | 4.58% | 3.51% | 4.23% | 8.48% | 4.25% | -1.65% | 0.66% | 2.99% | 4.14% | -0.09% | 12.81% | 0.02% | 3.54% | 18.51% |
| EPS | -0.89 | -0.71 | 1.93 | 1.41 | 0.42 | 3.50 | 3.69 | 3.12 | 4.05 | 9.18 | 4.68 | -2.13 | 0.30 | 1.11 | 1.50 | -0.05 | 5.37 | 0.03 | -0.18 | -1.86 |
| EPS Diluted | -0.90 | -0.71 | 1.93 | 1.38 | 0.41 | 3.48 | 3.66 | 3.12 | 4.02 | 9.06 | 4.62 | -2.13 | 0.30 | 1.11 | 1.50 | -0.05 | 5.37 | 0.03 | -0.18 | -1.86 |
| Weighted Avg Shares Out | 54.53M | 54.07M | 51.14M | 45.59M | 45.24M | 40.10M | 40.95M | 41.06M | 41.42M | 40.33M | 33.44M | 30.20M | 14.76M | 14.61M | 14.48M | 11.20M | 7.30M | 7.30M | 7.30M | 7.30M |
| Weighted Avg Shares Out (Dil) | 54.49M | 54.07M | 51.14M | 46.30M | 45.56M | 40.29M | 41.33M | 41.07M | 41.62M | 41.34M | 33.81M | 30.20M | 14.76M | 14.61M | 14.48M | 11.20M | 7.30M | 7.30M | 7.30M | 7.30M |
Source: https://incomestatements.info
Category: Stock Reports